These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9123173)

  • 1. Influence of indirect T-cell allorecognition on the immunosuppressive effects of multiple blood transfusions.
    Sawyer GJ; Fabre JW
    Transplant Proc; 1997; 29(1-2):1010-1. PubMed ID: 9123173
    [No Abstract]   [Full Text] [Related]  

  • 2. A three-cell cluster hypothesis for noncognate T-B cell collaboration via direct recognition of allogeneic dendritic cells.
    Kelly CM; Benham AM; Sawyer GJ; Dalchau R; Fabre J
    Transplant Proc; 1997; 29(1-2):1003-4. PubMed ID: 9123170
    [No Abstract]   [Full Text] [Related]  

  • 3. Indirect T-cell allorecognition and the mechanisms of immunosuppression by allogeneic blood transfusions.
    Sawyer GJ; Fabre JW
    Transpl Int; 1997; 10(4):276-83. PubMed ID: 9249937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.
    Fangmann J; Dalchau R; Fabre JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):183-4. PubMed ID: 8438266
    [No Abstract]   [Full Text] [Related]  

  • 5. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.
    Fangmann J; Dalchau R; Fabre JW
    J Exp Med; 1992 Jun; 175(6):1521-9. PubMed ID: 1588278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of alloimmunity with class I MHC peptides: mechanisms of action.
    Mhoyan A; Wu GD; Que X; Cramer DV; Shirwan H
    Transplant Proc; 1999; 31(1-2):1189-91. PubMed ID: 10083530
    [No Abstract]   [Full Text] [Related]  

  • 7. Intrathymic immunomodulation of sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
    Stadlbauer TH; Onodera K; Schaub M; Korom S; Binder J; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1997; 29(1-2):1016. PubMed ID: 9123176
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of donor class I major histocompatibility complex peptides in the induction of allograft tolerance.
    Shirwan H; Mhoyan A; Leamer M; Wang C; Cramer DV
    Transplant Proc; 1997; 29(1-2):1134-5. PubMed ID: 9123235
    [No Abstract]   [Full Text] [Related]  

  • 9. Modulation of the immune response with major histocompatability class II peptides via the indirect pathway of allorecognition after kidney and small bowel transplantation.
    Gasser M; Lenhard SM; Otto C; Kist-van Holthe JE; Navarro E; Timmermann W; Ulrichs K; Thiede A; Waaga AM
    Transplant Proc; 2002 Sep; 34(6):2244-5. PubMed ID: 12270384
    [No Abstract]   [Full Text] [Related]  

  • 10. Elucidation of key peptide determinants involved in an indirect T-cell allorecognition pathway of rat kidney allograft rejection.
    Benham AM; Fabre JW
    Transplant Proc; 1995 Feb; 27(1):547-8. PubMed ID: 7879093
    [No Abstract]   [Full Text] [Related]  

  • 11. Allorecognition of isolated, denatured chains of class I and class II major histocompatibility complex molecules. Evidence for an important role for indirect allorecognition in transplantation.
    Dalchau R; Fangmann J; Fabre JW
    Eur J Immunol; 1992 Mar; 22(3):669-77. PubMed ID: 1547813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to vascular endothelial cells in chronic rejection of renal allografts.
    Ball B; Mousson C; Ratignier C; Guignier F; Glotz D; Rifle G
    Transplant Proc; 2000 Mar; 32(2):353-4. PubMed ID: 10715436
    [No Abstract]   [Full Text] [Related]  

  • 13. T and B cell responsiveness to donor class I MHC molecules and peptides in long survivors with kidney allografts.
    Benham Am; Sawyer GJ; Fabre JW
    Transplantation; 1996 May; 61(10):1455-60. PubMed ID: 8633370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
    Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
    Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of allograft rejection in the rat by pretreatment with cells of the T-helper, but not T-cytotoxic suppressor phenotype.
    Cranston D; Wood KJ; Carter NP; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):505. PubMed ID: 2978918
    [No Abstract]   [Full Text] [Related]  

  • 16. Relative effects of major and minor histocompatibility locus antigens on the generation of suppressor activity by blood transfusions.
    Propper DJ; Stewart KN; Catto GR; MacLeod AM; Power DA
    Transplant Proc; 1991 Feb; 23(1 Pt 1):437-40. PubMed ID: 1824988
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of humoral immunity in pancreatic islet allo- and xenograft rejection.
    Ahn M; Sohn C; Chang E; Chu G; DeMatteo RP; Barker CF; Markmann JF
    Transplant Proc; 1996 Apr; 28(2):840-1. PubMed ID: 8623428
    [No Abstract]   [Full Text] [Related]  

  • 18. A three-cell cluster hypothesis for noncognate T-B collaboration via direct T cell recognition of allogeneic dendritic cells.
    Kelly CM; Benham AM; Sawyer GJ; Dalchau R; Fabre JW
    Transplantation; 1996 Apr; 61(7):1094-9. PubMed ID: 8623191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine specificity of peptide determinants for indirect T cell recognition of class I MHC alloantigens.
    Benham A; Fabre JW
    Transplantation; 1994 Dec; 58(11):1236-40. PubMed ID: 7527604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of alloantibody response to class I major histocompatibility complex by targeting synthetic allopeptides for presentation by B cells.
    MacDonald CM; Bolton EM; Jaques BC; Walker KG; Bradley JA
    Transplantation; 1997 Apr; 63(7):926-32. PubMed ID: 9112341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.